Sandoz Group AG
Open
67.02 -0.12
Overzicht
Wijziging aandelenprijs
24u
Min
66.52
Max
67.9
Inkomsten | 160M 537M |
|---|---|
Verkoop | 641M 5.9B |
K/W Sectorgemiddelde | 38.795 49.052 |
EPS | 1.238 |
Dividendrendement | 1.59 |
Winstmarge | 9.093 |
Werknemers | 22,356 |
EBITDA | 427M 1B |
Aanbevelingen | Buy |
|---|---|
12 Maanden Prognose | +10.39% upside |
Dividendrendement Sectorgemiddelde | 1.59% 2.36% |
|---|---|
Volgende Winsten | 5 aug 2026 |
Marktkapitalisatie | -1.1B 28B |
|---|---|
Vorige openingsprijs | 67.14 |
Vorige sluitingsprijs | 67.02 |
Sandoz Group AG Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Over Sandoz Group AG
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.
